Streetbeat News

Earnings

ITRM

Iterum Therapeutics (NASDAQ:ITRM) reported Q4 adjusted EPS losses of $(0.81), surpassing the analyst consensus estimate of $(0.93) by 12.9%. However, this represents a 55.77% increase in losses compared to $(0.52) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:50 pm

BLK

NKLA

NVDA

TSLA

The crypto market cap surpasses $2.6 trillion, driven by Dogecoin's spike and BlackRock's successful Bitcoin ETF. In US markets, Nvidia is removed from Piper Sandler's model portfolio, and the S&P 500 hits a new record. Biden's comprehensive policy for federal AI use is unveiled, amid various political and economic developments globally. In tech, significant investments in AI and lithium signal industry confidence. The electric vehicle sector sees mixed fortunes, with Tesla adjusting to Mexico's EV charging rules and Nikola launching a hydrogen fueling station.

Portfolio Pulse from Akanksha Bakshi

March 28, 2024 | 12:49 pm

DTST

Data Storage (NASDAQ:DTST) reported a significant improvement in Q4 EPS to $(0.01) from $(0.46) YoY, but missed sales estimates with $6.19M against the expected $6.30M. Sales increased by 3.72% YoY.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:47 pm

SPY

UUP

U.S. GDP growth for Q4 2023 was revised up to 3.4%, indicating solid economic activity despite a deceleration from the previous quarter's 4.9%. The revision was due to increased consumer spending and government investment, offset by lower private inventory and exports. Meanwhile, jobless claims were lower than expected, suggesting a strong labor market. The U.S. dollar strengthened following Fed remarks, impacting the Invesco DB USD Index Bullish Fund ETF (UUP), while the SPDR S&P 500 ETF Trust (SPY) reached a record high.

Portfolio Pulse from Piero Cingari

March 28, 2024 | 12:46 pm

CALC

CalciMedica (NASDAQ:CALC) reported a quarterly loss of $(0.23) per share for Q4.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:45 pm

CASI

CASI Pharmaceuticals reported Q4 losses of $(0.45) per share, missing the $(0.24) estimate, and sales of $6.87M, missing the $9.41M estimate. This represents a significant decrease in performance compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:45 pm

BETR

Better Home & Finance (NASDAQ:BETR) reported its Q4 sales at $9.25 million.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:44 pm

SBOW

SilverBow Resources reported a Q4 net income of $183M, or $7.12 per share, and highlighted its strategic implementation and business momentum. The company rejected Kimmeridge's proposal, deeming it undervalues SilverBow, and emphasized the need for due diligence on Kimmeridge Texas Gas (KTG) assets. SilverBow launched a website for shareholder information and filed a preliminary proxy statement for its 2024 annual meeting. The company also outlined governance enhancements and its commitment to shareholder value, citing significant progress and positive business momentum, including record Q4 results and a transformative acquisition in South Texas.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:43 pm

TAYD

Taylor Devices reported a significant increase in its Q3 2024 earnings per share (EPS) to $0.82 from $0.47 year-over-year (YoY). Sales also rose to $12.254 million from $9.891 million YoY.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:40 pm

ACHR

CCI

CMI

HOOD

Jim Cramer expressed skepticism towards Archer Aviation (ACHR) due to its lack of earnings power, following its worse-than-expected Q4 financial results. He also commented on Robinhood Markets (HOOD), advising caution after its recent price doubling and unveiling of the Robinhood Gold Card. Cramer recommended holding Cummins Inc. (CMI) after JPMorgan's price target increase and showed renewed interest in Crown Castle (CCI) due to its attractive yield and recent positive earnings report.

Portfolio Pulse from Avi Kapoor

March 28, 2024 | 12:39 pm